The rise of immunotherapy has undoubtedly transformed cancer treatment. While immunotherapy already combines a wide range of approaches, there are also other developments that have the potentialto provide powerful cures for malignancies. The variety of different approaches to fight tumors and new developments of pharma and biotech in the area of oncology are the focus of this session.

Chair: Ruth Herzog, Deutsches Krebsforschungszentrum

• Monica Binaschi. Menarini
• Krzysztof Brzózka, Selvita
• Niels Emmerich, Abbvie
• Steve Megit, Immunocore
• Sandra von Meier, Merck